Source: ppta-logo-38
In May 2025 podiatrists who have undertaken appropriate training were granted designated prescribing authority under the ‘Medicines (Designated Prescriber-Podiatrist) Regulations 2025’.
The Ministry of Health – Manatū Hauora (the Ministry), on behalf of the Director-General of Health, working with the Podiatrists Board of New Zealand, is responsible for establishing a list of specified prescription medicines that designated podiatrist prescribers can prescribe from.
In developing the list of specified prescription medicines, the Director-General must consult with those organisations or bodies that appear to the Director-General to be representative of persons likely to be substantially affected by the publication of the list of specified prescription medicines.
The Ministry undertook a consultation on the Podiatrists Board’s proposed specified prescription medicines list from 13 November to 20 December 2024. This Report provides details on the process to arrive at the list of prescription medicines considered appropriate for designated podiatrist prescribers.
